Sanofi (SNY) Invested Capital (2009 - 2025)

Sanofi (SNY) has 17 years of Invested Capital data on file, last reported at $104.9 billion in Q4 2025.

• Quarterly Invested Capital rose 4.78% year-over-year to $104.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $104.9 billion (up 4.78% YoY) and the FY2025 annual result came in at $104.9 billion, up 4.78% from the prior year.
• Invested Capital advanced to $104.9 billion in Q4 2025 per SNY's latest filing, from $87.8 billion in the prior quarter.
• The five-year high for Invested Capital was $104.9 billion in Q4 2025, with the low at $79.4 billion in Q2 2022.
• Average Invested Capital over 5 years is $93.8 billion, with a median of $96.7 billion recorded in 2022.
• Year-over-year, Invested Capital jumped 33.04% in 2021 and retreated 18.95% in 2022.
• Sanofi's Invested Capital stood at $101.7 billion in 2021, then declined by 5.73% to $95.9 billion in 2022, then advanced by 1.61% to $97.4 billion in 2023, then advanced by 2.69% to $100.1 billion in 2024, then climbed by 4.78% to $104.9 billion in 2025.
• Business Quant data shows SNY's Invested Capital at $104.9 billion in Q4 2025, $87.8 billion in Q2 2025, and $100.1 billion in Q4 2024.